Özyurt G, Çağan-Appak Y, Karakoyun M, Eliaçık K, Baran M. Father`s role in infantile anorexia. Turk J Pediatr 2018; 60: 608-611. Organic diseases account for only 16-30% of early feeding disorders. During the infancy period, mother-child relationship is in the center of feeding and disturbances in this relationship can also cause feeding disorders. Infantile anorexia (IA) usually begins within the first three years of age, but it has most commonly been observed to emerge between 9 and 18 months of age, a time during which babies transition to spoon and self-feeding. It is also worth noting that babies start to gain autonomy during this time frame. The present study discusses the case of an 8-month-old girl diagnosed with IA after ruling out food allergies, gastro-esophageal reflux disease, malrotation, and neurological problems. The patient was diagnosed with IA was treated with the relational regulation of parents and active participation of her father during the treatment process. It is found that mother-child relational disturbances and conflicts decreased dyadic reciprocity and non-appropriate affects in feeding times are associated with IA. Effective treatment strategies for non-organic feeding disorders might be developed by giving importance to maternal mental health and providing paternal involvement in baby caregiving.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.24953/turkjped.2018.05.024 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Editorial: Limitations on the Predictive Validity of the ARFID Diagnosis.
J Am Acad Child Adolesc Psychiatry
August 2024
Rogers Behavioral Health, Oconomowoc, Wisconsin and Philadelphia, Pennsylvania. Electronic address:
Avoidant/restrictive food intake disorder (ARFID) first entered the psychiatric nosology with the 2013 publication of DSM-5. Unlike binge eating disorder (BED), which was also new to DSM-5 but which had first been described by Stunkard in 1959, ARFID had never been described in the psychiatric literature as a single diagnostic entity. The new diagnosis encompassed clinical constructs that were previously proposed and studied but not described in DSM (ie, causes of "non-organic failure to thrive" including infantile anorexia and post-traumatic feeding disorder, and extreme food selectivity in children with autism spectrum disorder) and the DSM-IV Feeding Disorder of Infancy and Early Childhood (FDIEC).
View Article and Find Full Text PDFThe neurohypophyseal hormone oxytocin and eating behaviors: a narrative review.
Hormones (Athens)
March 2024
Interdisciplinary Department of Medicine, Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, University of Bari "Aldo Moro", School of Medicine, Bari, Apulia, Italy.
Article Synopsis
- Oxytocin (OT) is a hormone that helps with important things like breastfeeding and connecting with others, and it might also affect how we eat.
- Research shows that OT affects parts of the brain that control eating, and giving OT to rats made them eat less and lose weight.
- OT could help people with eating disorders by reducing hunger or, in some cases like anorexia, even making them want to eat more, but more studies are needed to understand how to use it effectively.
Efficacy and safety of thalidomide in children with monogenic autoinflammatory diseases: a single-center, real-world-evidence study.
Pediatr Rheumatol Online J
October 2023
Department of Pediatrics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.
Background: Monogenic autoinflammatory diseases (AIDs) are rare inflammatory diseases caused by genetic variants. The pathogenesis is complex and treatment options are limited. This study aimed to describe the safety and efficacy of thalidomide in the treatment of monogenic AIDs.
View Article and Find Full Text PDFShenqu xiaoshi oral solution enhances digestive function and stabilizes the gastrointestinal microbiota of juvenile rats with infantile anorexia.
J Ethnopharmacol
January 2024
School of Traditional Chinese Material, Shenyang Pharmaceutical University, Shenyang, 110016, China. Electronic address:
Ethnopharmacological Relevance: Massa Medicata Fermentata ("Shenqu") has long been applied in the treatment of indigestion in China; in fact, it is the active ingredient in the medicine Shenqu xiaoshi oral solution (SQXSOS). Based on robust clinical evidence, SQXSOS has shown efficacy in treating infantile anorexia (IFA).
Aim Of The Study: To investigate the underlying mechanisms by which SQXSOS treats IFA.
Failure to thrive in toddlers with lack of interest in eating and food and their cognitive development during later childhood.
Front Pediatr
August 2023
Department of Pedagogy, Psychology, Philosophy, University of Cagliari, Cagliari, Italy.
Background: Experiencing Failure to Thrive or malnutrition in early years has been associated with children later displaying low Intelligence Quotient (IQ). The current study's aim was to examine whether Failure to Thrive in Toddlers with Lack of Interest in Eating and Food, a subtype of Avoidant/Restrictive Food Intake Disorder as defined by DSM-5, which has also previously been identified as Infantile Anorexia (IA), was associated with poor cognitive development outcomes during later childhood.
Methods: The IQs and growth parameter of 30 children (53% female) previously diagnosed and treated for IA at 12 to 42 months of age, were reevaluated at a mean age of 10.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!